Innovation and collaboration – the MHRA’s pandemic approachThe pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, Share XInnovation and collaboration – the MHRA’s pandemic approachhttps://pharmaphorum.com/market-access-2/mhra-pandemic-approach-innovation-collaboration/
Are we measuring what matters most on uptake to medicines in England?In the second of a two-part series, Leela Barham argues that whilst international comparisons of uptake are useful, Share XAre we measuring what matters most on uptake to medicines in England?https://pharmaphorum.com/market-access-2/measuring-uptake-medicines-england/
Getting better at measuring international uptake of medicines?In part one of a two-piece series, Leela Barham looks at whether we are getting better at measuring Share XGetting better at measuring international uptake of medicines?https://pharmaphorum.com/market-access-2/getting-better-at-measuring-international-uptake-of-medicines/
A test of NICE’s resolve: clinical guidelines for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)The work of the UK’s HTA body, the National Institute for Health and Care Excellence (NICE), is often Share XA test of NICE’s resolve: clinical guidelines for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)https://pharmaphorum.com/views-and-analysis/guidelines-myalgic-encephalomyelitis-chronic-fatigue-syndrome/
COVID-19 has propelled the regulatory industry years aheadJanssen’s Saskia De Haes, VP EMEA Regulatory Affairs, looks at how the pandemic response has shaped tomorrow’s regulatory Share XCOVID-19 has propelled the regulatory industry years aheadhttps://pharmaphorum.com/views-and-analysis/covid-19-has-propelled-the-regulatory-industry-years-ahead/
A problem combination?Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge Share XA problem combination?https://pharmaphorum.com/views-and-analysis/a-problem-combination/
Collaborate to simplify cancer trials and accelerate post-pandemic recoveryHow could simplifying the administration of clinical trials help cancer diagnosis, care, and treatment levels to exceed pre-pandemic Share XCollaborate to simplify cancer trials and accelerate post-pandemic recoveryhttps://pharmaphorum.com/views-and-analysis/collaborate-to-simplify-cancer-trials-and-accelerate-post-pandemic-recovery/
NICE feedback?The National Institute for Health and Care Excellence (NICE) is quite far along a NICE-led process to review Share XNICE feedback?https://pharmaphorum.com/views-and-analysis/nice-feedback/
How digital pathways are changing healthcareAs demonstrated throughout COVID, digital health is no longer experimental. Digital technologies are proving their value by allowing Share XHow digital pathways are changing healthcarehttps://pharmaphorum.com/digital/how-digital-pathways-are-changing-healthcare/
